…
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
DuPont de Nemours is a global specialty chemical and materials company that supplies high-performance polymers, coatings and engineered materials for electronics, transportation, industrial and safety applications. Its long-term growth may be supported by rising demand for electronics and electrification, sustainability-driven materials substitution and ongoing R&D, and the company appears positioned with diversified end-markets and a global manufacturing footprint that could support higher-margin specialty sales.
Material risks include cyclical exposure to industrial end-markets, volatility in raw-material and energy costs, intense competition from larger chemical peers and regulatory or environmental liabilities investors should monitor.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 200.00M | 1192.00M | 504.00M | 1448.00M | 1444.00M |
| Minority interest | -41.00M | -35.00M | -43.00M | -49.00M | -48.00M |
| Net income | -779.00M | 703.00M | 423.00M | 1061.00M | 1177.00M |
| Selling general administrative | 1019.00M | 1552.00M | 1408.00M | 1467.00M | 1855.00M |
| Selling and marketing expenses | - | - | 9.00M | - | - |
| Gross profit | 2072.00M | 3912.00M | 3633.00M | 4615.00M | 4595.00M |
| Reconciled depreciation | 647.00M | 1194.00M | 1172.00M | 1180.00M | 1458.00M |
| Ebit | 513.00M | 1558.00M | 900.00M | 2288.00M | 2100.00M |
| Ebitda | 1160.00M | 2752.00M | 2047.00M | 3468.00M | 2666.00M |
| Depreciation and amortization | 647.00M | 1194.00M | 1147.00M | 1180.00M | 566.00M |
| Non operating income net other | - | - | - | 266.00M | 257.00M |
| Operating income | 860.00M | 1829.00M | 1717.00M | 2288.00M | 2100.00M |
| Other operating expenses | 5989.00M | 10557.00M | 10351.00M | 10995.00M | 10696.00M |
| Interest expense | 313.00M | 366.00M | 396.00M | 492.00M | 525.00M |
| Tax provision | 102.00M | 414.00M | 375.00M | 387.00M | 392.00M |
| Interest income | 320.00M | 73.00M | 174.00M | 417.00M | 619.00M |
| Net interest income | -215.00M | -293.00M | -243.00M | -492.00M | -525.00M |
| Extraordinary items | -836.00M | -40.00M | -71.00M | 4786.00M | 4711.00M |
| Income tax expense | 102.00M | 414.00M | -29.00M | 387.00M | 237.00M |
| Total revenue | 6849.00M | 12386.00M | 12068.00M | 13017.00M | 12566.00M |
| Total operating expenses | 1212.00M | 2083.00M | 1916.00M | 2593.00M | 2725.00M |
| Cost of revenue | 4777.00M | 8474.00M | 8435.00M | 8402.00M | 7971.00M |
| Total other income expense net | -660.00M | -637.00M | -1213.00M | -840.00M | -656.00M |
| Discontinued operations | - | - | - | 4856.00M | 4711.00M |
| Net income from continuing ops | 98.00M | 778.00M | 938.00M | 1061.00M | 1804.00M |
| Net income applicable to common shares | -779.00M | 703.00M | 423.00M | 5798.00M | 6467.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 21575.00M | 36636.00M | 38552.00M | 41400.00M | 45707.00M |
| Intangible assets | 2936.00M | 5370.00M | 5814.00M | 5495.00M | 8442.00M |
| Other current assets | 1977.00M | 185.00M | 605.00M | 168.00M | 236.00M |
| Total liab | 7472.00M | 12843.00M | 13827.00M | 14453.00M | 18657.00M |
| Total stockholder equity | 13919.00M | 23350.00M | 24279.00M | 26499.00M | 26433.00M |
| Deferred long term liab | - | - | - | 439.00M | 1479.00M |
| Other current liab | 1196.00M | 1031.00M | 1269.00M | 1445.00M | 25.00M |
| Common stock | 4.00M | 4.00M | 4.00M | 5.00M | 5.00M |
| Capital stock | 4.00M | 4.00M | 4.00M | 5.00M | 5.00M |
| Retained earnings | -24278.00M | -23076.00M | -22874.00M | -21135.00M | -23187.00M |
| Other liab | - | - | - | 2427.00M | 3763.00M |
| Good will | 7915.00M | 16567.00M | 16720.00M | 16663.00M | 19578.00M |
| Other assets | 1253.00M | 1083.00M | 1065.00M | 1463.00M | 1675.00M |
| Cash | 757.00M | 1850.00M | 2392.00M | 3662.00M | 2011.00M |
| Cash and equivalents | 715.00M | 1850.00M | 2392.00M | 3662.00M | 2011.00M |
| Total current liabilities | 2305.00M | 4801.00M | 3098.00M | 3848.00M | 4262.00M |
| Current deferred revenue | - | - | 1.00M | - | 1475.00M |
| Net debt | 2437.00M | 5321.00M | 5408.00M | 4412.00M | 8771.00M |
| Short term debt | 60.00M | 1848.00M | 97.00M | 300.00M | 150.00M |
| Short long term debt | 60.00M | 1848.00M | - | 300.00M | 150.00M |
| Short long term debt total | 3194.00M | 7171.00M | 7800.00M | 8074.00M | 10782.00M |
| Other stockholder equity | 38718.00M | 47922.00M | 48059.00M | 48420.00M | 49574.00M |
| Property plant equipment | 3464.00M | 6171.00M | 6368.00M | 5731.00M | 6966.00M |
| Total current assets | 5575.00M | 6364.00M | 7514.00M | 11315.00M | 8065.00M |
| Long term investments | 432.00M | 1081.00M | 1071.00M | 733.00M | 981.00M |
| Net tangible assets | - | - | - | 26569.00M | -1587.00M |
| Short term investments | - | - | -411.00M | 1302.00M | - |
| Net receivables | 1669.00M | 2199.00M | 2370.00M | 2518.00M | 2711.00M |
| Long term debt | 3134.00M | 5323.00M | 7731.00M | 7774.00M | 10632.00M |
| Inventory | 1172.00M | 2130.00M | 2147.00M | 2329.00M | 2862.00M |
| Accounts payable | 995.00M | 1720.00M | 1675.00M | 2103.00M | 2612.00M |
| Noncontrolling interest in consolidated entity | - | - | - | 448.00M | 617.00M |
| Accumulated other comprehensive income | -525.00M | -1500.00M | -910.00M | -791.00M | 41.00M |
| Common stock total equity | - | - | - | 5.00M | 5.00M |
| Retained earnings total equity | - | - | - | -21065.00M | -23187.00M |
| Non currrent assets other | 971.00M | 1240.00M | 753.00M | 1354.00M | 1532.00M |
| Non current assets total | 16000.00M | 30272.00M | 31038.00M | 30085.00M | 37642.00M |
| Capital lease obligations | 9.00M | 9.00M | 10.00M | - | 2.00M |
| Long term debt total | 3134.00M | 5323.00M | 7800.00M | 7774.00M | 10632.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.00M | -849.00M | 8133.00M | 8923.00M | -2401.00M |
| Change to liabilities | - | - | - | -131.00M | 317.00M |
| Total cashflows from investing activities | -687.00M | -849.00M | 172.00M | 8923.00M | -2401.00M |
| Net borrowings | -4074.00M | -687.00M | -300.00M | -2650.00M | -3600.00M |
| Total cash from financing activities | -1868.00M | -1847.00M | -2989.00M | -7667.00M | -6507.00M |
| Change to operating activities | - | - | - | -476.00M | 25.00M |
| Net income | 98.00M | 743.00M | 494.00M | 5847.00M | 6515.00M |
| Change in cash | -1099.00M | -947.00M | -866.00M | 1696.00M | -6699.00M |
| Begin period cash flow | 1856.00M | 2803.00M | 3669.00M | 2076.00M | 8775.00M |
| End period cash flow | 757.00M | 1856.00M | 2803.00M | 3772.00M | 2076.00M |
| Total cash from operating activities | 1412.00M | 1847.00M | 2191.00M | 588.00M | 2281.00M |
| Issuance of capital stock | 32.00M | 50.00M | 27.00M | 88.00M | 115.00M |
| Depreciation | 647.00M | 1194.00M | 1147.00M | 1180.00M | 1458.00M |
| Other cashflows from investing activities | -296.00M | 43.00M | 6.00M | 9666.00M | -1510.00M |
| Dividends paid | 597.00M | 635.00M | 651.00M | 652.00M | 630.00M |
| Change to inventory | -10.00M | -7.00M | 227.00M | -569.00M | -537.00M |
| Change to account receivables | -201.00M | -135.00M | 202.00M | -191.00M | -255.00M |
| Sale purchase of stock | -500.00M | -500.00M | -2000.00M | -4375.00M | -2143.00M |
| Other cashflows from financing activities | 3271.00M | -75.00M | -65.00M | 522.00M | 1151.00M |
| Change to netincome | - | - | - | -5135.00M | -5194.00M |
| Capital expenditures | 333.00M | 579.00M | 619.00M | 743.00M | 3237.00M |
| Change receivables | - | - | - | -191.00M | -255.00M |
| Cash flows other operating | - | - | - | -1052.00M | -501.00M |
| Cash and cash equivalents changes | - | - | - | 1844.00M | -6627.00M |
| Change in working capital | -313.00M | 222.00M | -155.00M | -1367.00M | -450.00M |
| Stock based compensation | 38.00M | 77.00M | 74.00M | - | -5084.00M |
| Other non cash items | 942.00M | -149.00M | 1086.00M | -4928.00M | 165.00M |
| Free cash flow | 1079.00M | 1268.00M | 1572.00M | -155.00M | -956.00M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DD Dupont De Nemours Inc |
1.59 1.10% |
146.52 | 222.43 | 20.33 | 2.80 | 1.38 | 3.16 | 18.64 |
| LIN Linde plc Ordinary Shares |
-5.98 1.15% |
515.25 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.75 1.77% |
41.68 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
0.00 0.00% |
211.18 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-4.96 1.42% |
344.05 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
| Name | Title | Year Born |
|---|---|---|
| Mr. Edward D. Breen | CEO & Exec. Chairman | 1956 |
| Ms. Lori D. Koch | Exec. VP & CFO | 1975 |
| Mr. Erik T. Hoover | Sr. VP & Gen. Counsel | 1974 |
| Mr. Jon D. Kemp | Pres of Electronics & Industrial | 1977 |
| Mr. Daryl Roberts | Sr. VP and Chief Operations & Engineering Officer | 1969 |
| Mr. Michael G. Goss | VP, Controller & Principal Accounting Officer | 1977 |
| Ms. Alexa Dembek | Sr. VP and Chief Technology & Sustainability Officer | NA |
| Mr. Steven P. Larrabee | Sr. VP & Chief Information Officer | 1962 |
| Mr. Christopher H. Mecray | VP of Investor Relations | NA |
| Mr. Christopher Raia | Sr. VP & Chief HR Officer | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.